| Journal of Animal Biology & Therapeutics
Published Online: 30 September 2026.
J. Anim. Biol. Ther., 2026, 1(1), 26705| Volume 1 Issue 1 (September 2026) | DOI: https://doi.org/10.64189/abt.26705
© The Author(s) 2026
This article is licensed under Creative Commons Attribution NonCommercial 4.0 International (CC-BY-NC 4.0)
Advancing Animal Health: From Diagnostic Precision
to Novel Therapeutics
Lachhman Das Singla
*
Department of Veterinary Parasitology, School of Veterinary Sciences, Abhilashi University, Mandi, Himachal Pradesh, 175045, India
*Email: eic.abt@gr-journals.com (Lachhman Das Singla)
The intrinsic convergence of human, animal, and environmental health underpins modern biomedical
science.
[1–3]
At the nexus of this triadic interaction lie infectious diseases, which impair animal welfare and
agricultural productivity, compromise global food security, and present persistent zoonotic risks.
[3]
The
control of these pathogens is increasingly confounded by antimicrobial resistance (AMR), driven in part by
widespread antimicrobial use in food-producing animals, with serious public health ramifications.
[4,5]
Addressing these challenges necessitates robust diagnostic frameworks, rational therapeutics, and innovative
pharmacological interventions across veterinary and comparative animal sciences.
In response to these critical needs, we introduce the inaugural issue of the Journal of Animal Biology &
Therapeutics, a peer-reviewed, open-access forum dedicated to advancing research in veterinary medicine,
animal science, and the health, welfare, and productivity of domestic, wildlife, aquatic, and laboratory species.
Embracing the One Health and One Welfare paradigms, the journal serves as a multidisciplinary platform for
high-impact original research, systematic reviews, meta-analyses, and clinical communications.
[1,2,6]
Our inaugural issue features four contributions that collectively span the continuum from individual clinical
diagnosis, through novel therapeutic strategies, to point-of-care field surveillance and clinical case
management: Kaur et al. provide a comprehensive review of nanomedicine applications against human and
veterinary helminthiases. The authors synthesize host-parasite immunobiology, anthelmintic resistance
mechanisms, and plant-derived phytochemicals alongside nanoparticle-based drug delivery architectures.
They highlight how nanocarriers enhance bioavailability, targeted delivery, and cellular uptake, potentially
bypassing canonical drug-efflux mechanisms while emphasizing the translational hurdles remaining for
clinical adoption.
[7]
Garcês et al. document a novel fatal presentation of masticatory myositis with extensive
intracranial involvement in an albino Bennett’s wallaby (Notamacropus rufogriseus).Comprehensive necropsy,
histopathology, and microbiological evaluation revealed severe necrotizing and suppurative myositis
secondary to Enterobacter cloacae complex and Enterococcus faecalis infection, likely precipitated by oral soft-
tissue trauma. Crucially, the absence of osteolytic changes differentiates this acute phlegmonous process from
classic macropodid actinomycosis ("lumpy jaw"), highlighting the necessity of systematic post-mortem
evaluations in wildlife diagnostics.
[8]
Eravaramkunnath et al. report a severe case of feline babesiosis in a
domestic cat in Kerala, India, characterized by profound anemia, leukopenia, and thrombocytopenia.
Diagnosis was established via Giemsa-stained peripheral blood smear microscopy showing intraerythrocytic
piroplasms, and successful clinical resolution was achieved using a combination regimen of diminazene
aceturate and doxycycline. The case underscores the diagnostic utility of routine hematology in resource-
constrained practices while illustrating the need for accessible molecular diagnostics for definitive species-
level identification.
[9]
Udhayavel et al. developed and validated a novel latex agglutination test (LAT)
employing whole-cell protein antigens of Mycoplasma ovipneumoniae for small ruminants. Evaluated against
real-time PCR, the assay demonstrated high diagnostic sensitivity (93.94%) and specificity (93.51%) with
strong concordance (𝜅 = 0.852).
This rapid, low-cost penside assay offers an effective solution for
epidemiological screening and flock-level disease management in low-resource field settings.
[10]
Collectively, these inaugural contributions demonstrate that safeguarding animal health relies on precise
diagnostics, field-deployable tools, and rational therapeutic development. They also delineate recurrent
translational challenges, such as pathogen speciation, drug resistance, and laboratory-to-field
implementation, which we encourage future contributors to address.
The Editorial Office remains dedicated to a rigorous, transparent, and timely peer-review process adhering to
the highest standards of scientific and ethical integrity. We warmly invite researchers, clinicians, and
epidemiologists to contribute their work and assist in establishing the Journal of Animal Biology &
Therapeutics as a leading venue for integrative animal health sciences.
Conflict of Interest
The author is a co-author of one article featured in this issue (Ref. 8); its peer review and editorial handling
were carried out independently of the author.
Artificial Intelligence (AI) Use Disclosure
The author declares that artificial intelligence (AI)-assisted tools were used only for language refinement,
grammar improvement, and manuscript structuring purposes during the preparation of this work. All content
and interpretations were reviewed and verified by the author.
References
[1]
W. B. Adisasmito, S. Almuhairi, C. B. Behravesh, P. Bilivogui, S. A. Bukachi, N. Casas, N. C. Becerra, D. F.
Charron, A. Chaudhary, J. R. Ciacci Zanella, A. A. Cunningham, O. Dar, N. Debnath, B. Dungu, E. Farag,
G. F. Gao, D. T. S. Hayman, M. Khaitsa, M. P. G. Koopmans, C. Machalaba, J. S. Mackenzie, W. Markotter,
T. C. Mettenleiter, S. Morand, V. Smolenskiy, L. Zhou, One health: A new definition for a sustainable
and healthy future, PLOS Pathogens, 2022, 18, e1010537, doi: 10.1371/journal.ppat.1010537.
[2]
R. García Pinillos, M. C. Appleby, X. Manteca, F. Scott-Park, C. Smith, A. Velarde, One welfare - a
platform for improving human and animal welfare, Veterinary Record, 2016, 179, 412-413, doi:
10.1136/vr.i5470.
[3]
M. E. Woolhouse, S. Gowtage-Sequeria, Host range and emerging and reemerging pathogens,
Emerging Infectious Diseases, 2005, 11, 1842–1847, doi: 10.3201/eid1112.050997.
[4]
R. Mulchandani, Y. Wang, M. Gilbert, T. P. Van Boeckel, Global trends in antimicrobial use in food-
producing animals: 2020 to 2030, PLOS Global Public Health, 2023, 3, e0001305, doi:
10.1371/journal.pgph.0001305.
[5]
K. L. Tang, N. P. Caffrey, D. B. Nóbrega, S. C. Cork, P. E. Ronksley, H. W. Barkema, A. J. Polachek, H.
Ganshorn, N. Sharma, J. D. Kellner, W. A. Ghali, Restricting the use of antibiotics in food-producing
animals and its association with antibiotic resistance in food-producing animals and human beings: a
systematic review and meta-analysis, The Lancet Planetary Health, 2017, 1, e316–e327, doi:
10.1016/S2542-5196(17)30141-9.
[6]
D. M. Broom, A history of animal welfare science, Acta Biotheoretica, 2011, 59, 121–137, doi:
10.1007/s10441-011-9123-3.
[7]
H. Kaur, L. D. Singla, D. Choudhury, Nanomedicine for human and veterinary helminthiasis:
Anthelmintic delivery, resistance, and host–parasite interactions, Journal of Animal Biology &
Therapeutics, 2026, 1, 26702, doi: 10.64189/abt.26702.
[8]
A. Garcês, L. Sousa, C. Cardoso, R. Sargo, L. Monteiro, D. Silva, R. Lopes, F. Silva, J. Prada, Fatal
necrotizing and suppurative masticatory myositis with intracranial involvement in an Albino
Bennett's Wallaby (Notamacropus rufogriseus), Journal of Animal Biology & Therapeutics, 2026, 1,
26701, doi: 10.64189/abt.26701.
[9]
F. Eravaramkunnath, F. Dhina, A. R. N. S. Devi, B. Lakshmanan, A case report of Babesia sp. in feline
host: Diagnosis and successful outcome, Journal of Animal Biology & Therapeutics, 2026, 1, 26704,
doi: 10.64189/abt.26704.
[10]
S. Udhayavel, K. Sukumar, K. Senthilkumar, P. Srinivasan, A. Elango, Development of a Latex
Agglutination Test (LAT) using whole-cell protein for the detection of Mycoplasma ovipneumoniae
antibodies in small ruminants, Journal of Animal Biology & Therapeutics, 2026, 1, 26703, doi:
10.64189/abt.26703.
Publisher Note: The views, statements, and data in all publications solely belong to the authors and
contributors. GR Scholastic is not responsible for any injury resulting from the ideas, methods, or products
mentioned. GR Scholastic remains neutral regarding jurisdictional claims in published maps and institutional
affiliations.
Open Access
This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License,
which permits the non-commercial use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as appropriate credit to the original author(s) and the source is given by providing a link to the
Creative Commons License and changes need to be indicated if there are any. The images or other third-party
material in this article are included in the article's Creative Commons License, unless indicated otherwise in a
credit line to the material. If material is not included in the article's Creative Commons License and your
intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
